Pages that link to "Q51803777"
Jump to navigation
Jump to search
The following pages link to Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates (Q51803777):
Displaying 50 items.
- Bisphosphonates in multiple myeloma: a network meta-analysis (Q24197839) (← links)
- Bisphosphonates and other bone agents for breast cancer (Q24203656) (← links)
- Radioisotopes for metastatic bone pain (Q24235589) (← links)
- The role of RANK-ligand inhibition in cancer: the story of denosumab (Q24633284) (← links)
- Denosumab (Q24651938) (← links)
- Bone Metastasis from Renal Cell Carcinoma (Q26747493) (← links)
- Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS) (Q26747566) (← links)
- Targeted immunotherapy for pediatric solid tumors (Q26747703) (← links)
- Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis (Q26749368) (← links)
- Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer (Q26752785) (← links)
- Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients (Q26824762) (← links)
- Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions (Q26863326) (← links)
- Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences (Q26863493) (← links)
- Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement (Q27011865) (← links)
- Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer (Q27021268) (← links)
- Prostate cancer: ESMO Consensus Conference Guidelines 2012 (Q27022847) (← links)
- Targeting tumor-stromal interactions in bone metastasis (Q27024561) (← links)
- Biology of bone metastases (Q27693653) (← links)
- Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer (Q28079918) (← links)
- Bone-targeted therapy in metastatic breast cancer - all well-established knowledge? (Q28087676) (← links)
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab (Q28265584) (← links)
- RANKL/RANK-beyond bones (Q28308042) (← links)
- Considering renal risk while managing cancer (Q30234338) (← links)
- Radium-223 dichloride in clinical practice: a review. (Q30251496) (← links)
- Role of denosumab in prostate cancer (Q30455154) (← links)
- WITHDRAWN: Radioisotopes for metastatic bone pain (Q33440341) (← links)
- Novel targeted therapeutics for metastatic castration-resistant prostate cancer. (Q33642278) (← links)
- Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis. (Q33720969) (← links)
- Prostate cancer and bone: the elective affinities. (Q33757791) (← links)
- Targeted treatments of bone metastases in patients with lung cancer (Q33759713) (← links)
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer (Q33827254) (← links)
- Bone-targeting agents in prostate cancer (Q33864723) (← links)
- Osteonecrosis of the jaw in a patient on Denosumab (Q33891868) (← links)
- The best of both worlds - managing the cancer, saving the bone (Q33920055) (← links)
- Bone health and prostate cancer (Q33977536) (← links)
- Future directions of bone-targeted therapy for metastatic breast cancer (Q34023727) (← links)
- Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer (Q34023877) (← links)
- Novel therapeutic targets in myeloma bone disease (Q34025065) (← links)
- Bone metastasis: mechanisms and therapeutic opportunities (Q34025195) (← links)
- Interleukin-6 in bone metastasis and cancer progression. (Q34051820) (← links)
- Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases (Q34101059) (← links)
- Preventing Bone Complications in Advanced Prostate Cancer (Q34111634) (← links)
- Targeting Continued Androgen Receptor Signaling in Prostate Cancer (Q34193298) (← links)
- RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis (Q34209272) (← links)
- A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer (Q34322294) (← links)
- Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. (Q34381979) (← links)
- Integrins and bone metastasis: integrating tumor cell and stromal cell interactions (Q34441622) (← links)
- Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasis (Q34448130) (← links)
- Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype (Q34490721) (← links)
- The Treatment of Spinal Metastases (Q34565775) (← links)